Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study
- PMID: 34699771
- PMCID: PMC8941605
- DOI: 10.1016/j.chest.2021.10.021
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study
Abstract
Background: The adherence to and clinical efficacy of pulmonary rehabilitation in idiopathic pulmonary fibrosis (IPF), particularly in comparison with COPD, remains uncertain. The objectives of this real-world study were to compare the responses of patients with IPF with a matched group of patients with COPD undergoing the same supervised, outpatient pulmonary rehabilitation program and to determine whether pulmonary rehabilitation is associated with survival in IPF.
Research question: Do people with IPF improve to the same extent with pulmonary rehabilitation as a matched group of individuals with COPD, and are noncompletion of or nonresponse to pulmonary rehabilitation, or both, associated with 1-year all-cause mortality in IPF?
Study design and methods: Using propensity score matching, 163 patients with IPF were matched 1:1 with a control group of 163 patients with COPD referred for pulmonary rehabilitation. We compared between-group pulmonary rehabilitation completion rates and response. Survival status in the IPF cohort was recorded over 1 year after pulmonary rehabilitation discharge. Cox proportional hazards regression explored the association between pulmonary rehabilitation status and all-cause mortality.
Results: Similar pulmonary rehabilitation completion rates (IPF, 69%; COPD, 63%; P = .24) and improvements in exercise response were observed in both groups with no significant mean between-group differences in incremental shuttle walk test (ISWT) change (mean, 2 m [95% CI, -18 to 22 m]). Pulmonary rehabilitation noncompletion (hazard ratio [HR], 5.62 [95% CI, 2.24-14.08]) and nonresponse (HR, 3.91 [95% CI, 1.54-9.93]) were associated independently with increased 1-year all-cause mortality in IPF.
Interpretation: This real-word study demonstrated that patients with IPF have similar completion rates and magnitude of response to pulmonary rehabilitation compared with a matched group of patients with COPD. In IPF, noncompletion of and nonresponse to pulmonary rehabilitation were associated with increased all-cause mortality. These data reinforce the benefits of pulmonary rehabilitation in patients with IPF.
Keywords: COPD; idiopathic pulmonary fibrosis; prognosis; pulmonary rehabilitation.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Walk a Mile in My Shoes: Assessing the Importance of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis.Chest. 2022 Mar;161(3):597-598. doi: 10.1016/j.chest.2021.11.018. Chest. 2022. PMID: 35256076 No abstract available.
-
Challenging the Evidence for Pulmonary Rehabilitation in Pulmonary Fibrosis: Is Good, Enough?Chest. 2022 Mar;161(3):599-600. doi: 10.1016/j.chest.2021.11.017. Chest. 2022. PMID: 35256077 No abstract available.
Similar articles
-
Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.Respiration. 2011;81(3):196-205. doi: 10.1159/000315475. Epub 2010 May 27. Respiration. 2011. PMID: 20516666 Clinical Trial.
-
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.Respir Res. 2024 Jun 19;25(1):249. doi: 10.1186/s12931-024-02875-2. Respir Res. 2024. PMID: 38898447 Free PMC article.
-
Pulmonary rehabilitation in bronchiectasis: a propensity-matched study.Eur Respir J. 2019 Jan 17;53(1):1801264. doi: 10.1183/13993003.01264-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30578381
-
Pulmonary hypertension in chronic lung diseases.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
-
[The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis].Harefuah. 2012 Apr;151(4):220-4, 253. Harefuah. 2012. PMID: 22616150 Review. Hebrew.
Cited by
-
Effect of pulmonary rehabilitation on all-cause mortality in patients with chronic respiratory disease: a retrospective cohort study in an Australian teaching hospital.BMC Pulm Med. 2024 Oct 10;24(1):501. doi: 10.1186/s12890-024-03319-9. BMC Pulm Med. 2024. PMID: 39390462 Free PMC article.
-
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024038. doi: 10.36141/svdld.v41i3.15530. Sarcoidosis Vasc Diffuse Lung Dis. 2024. PMID: 39315980 Free PMC article.
-
Pulmonary hypertension associated with lung diseases.Eur Respir J. 2024 Oct 31;64(4):2401200. doi: 10.1183/13993003.01200-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209469 Free PMC article. Review.
-
Protected characteristics reported in pulmonary rehabilitation: a scoping review.Eur Respir Rev. 2024 Jun 12;33(172):230236. doi: 10.1183/16000617.0236-2023. Print 2024 Apr. Eur Respir Rev. 2024. PMID: 39009405 Free PMC article. Review.
-
The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.PLoS One. 2024 Mar 13;19(3):e0299484. doi: 10.1371/journal.pone.0299484. eCollection 2024. PLoS One. 2024. PMID: 38478558 Free PMC article.
References
-
- Fell C.D. Idiopathic pulmonary fibrosis: phenotypes and comorbidities. Clin Chest Med. 2012;33(1):51–57. - PubMed
-
- Holland A.E., Fiore J.F., Bell E.C., et al. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014;19(8):1215–1221. - PubMed
-
- Noble P.W., Albera C., Bradford W.Z., et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011;377(9779):1760–1769. - PubMed
-
- Richeldi L., du Bois R.M., Raghu G., et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
